De-risk your programbefore someone else's diligence does
The science, the competitive landscape and the evidence against your target, every claim traceable to its source.
Your queries are encrypted. ISO 27001 certified.
Biotech teams using Causaly
Trusted by the world's leading biopharma companies
Different challenges at different stages
What a team needs to know changes as a program moves from target to clinic. Causaly can help with the decision you're facing at a given moment, whether it's about core biology, preparing for an investor conversation, or building an evidence plan.
Is this target worth our next six months, and what is the on-target risk?
- A small team covering biology outside each person's expertise
- Targets that look strong on paper fail on on-target, off-disease effects
- Human genetics, expression and safety evidence sit in different places
The questions to anticipate at your next investor conversation
Typical questions and tasks real biotech teams use Causaly Research for.
Every competing asset on your target, by phase, modality and company, including the early entrants a quick search misses.
“Companies live and die based on the identification and veracity of their targets.”
How Manas AI validates targets with Causaly
- One evidence assessment for every candidate target, before resources are committed.
- Human genetics, preclinical findings, phase 1 and 2 results, competitor activity and adverse effects graded by severity, in one structured view.
- Used again later in the pipeline as a sanity check, feeding clinical signals back into target decisions.
See exactly where every answer comes from
- Click any citation, read the sentence. The source opens on the highlighted passage the claim rests on.
- The evidence against is shown, not hidden. Supporting and refuting findings sit side by side.
- When the evidence isn't there, it says so. It names its assumptions and the gaps it couldn't close.
It held its hand up and said it didn't know… it was just actually quite refreshing.
Built for science, measured against general AI
Same research questions, three tools. Causaly finds more of the evidence that matters and cites nothing off-topic.
vs. 42% for ChatGPT and 20% for Claude
with 100% groundedness in the evaluation
vs. 7% for ChatGPT and 30% for Claude
Your research stays yours
The target or mode of action you're investigating in stealth, the data you generate in your proof of concept: that's your IP. We treat it that way.
- Is our data used to train models?
- No. Your questions and documents are never used to train models.
- Who can see our work?
- Only the people you share it with.
- Is our data encrypted?
- Yes, in transit and at rest.
- What security certifications does Causaly have?
- Causaly is ISO 27001 certified, the international standard for information security.
Your whole team, working from the same evidence
When the biologist, the clinician and the CEO start from the same sourced answers, the science, the clinical plan and the investor story stay consistent, and nobody repeats a search a colleague already ran.
Walk into your next investor meeting with the answers.
See your target, your landscape and the evidence against it, every claim sourced.
Start your free trial